1. Home
  2. NNNN vs IMRX Comparison

NNNN vs IMRX Comparison

Compare NNNN & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$4.90

Market Cap

270.4M

Sector

Health Care

ML Signal

N/A

Logo Immuneering Corporation

IMRX

Immuneering Corporation

SELL

Current Price

$3.86

Market Cap

313.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NNNN
IMRX
Founded
2021
2008
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.4M
313.8M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
NNNN
IMRX
Price
$4.90
$3.86
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $17.17
AVG Volume (30 Days)
199.7K
★ 631.4K
Earning Date
10-23-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.75
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.66
$3.86
52 Week High
$44.73
$8.48

Technical Indicators

Market Signals
Indicator
NNNN
IMRX
Relative Strength Index (RSI) 28.21 26.80
Support Level N/A N/A
Resistance Level $6.95 $5.32
Average True Range (ATR) 0.55 0.16
MACD 0.05 -0.05
Stochastic Oscillator 7.01 0.00

Price Performance

Historical Comparison
NNNN
IMRX

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: